Lixte Biotechnology Holdings Inc. (NASDAQ: LIXT) Stock Information | RedChip

Lixte Biotechnology Holdings Inc. (NASDAQ: LIXT)


$2.1500
+0.0900 ( +5.39% ) 4.7K

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Market Data


Open


$2.1500

Previous close


$2.0600

Volume


4.7K

Market cap


$4.84M

Day range


$1.9920 - $2.1890

52 week range


$1.3100 - $4.4000

SEC Filings


Form Type Description Pages Date
8-k 8K-related 15 Jun 14, 2024
8-k 8K-related 15 Jun 14, 2024
8-k 8K-related 16 Jun 05, 2024
8-k 8K-related 14 May 29, 2024
8-k 8K-related 15 May 20, 2024
8-k 8K-related 16 May 09, 2024
10-q Quarterly Reports 58 May 09, 2024
8-k 8K-related 15 Mar 28, 2024
8-k 8K-related 16 Mar 22, 2024
10-k Annual reports 70 Mar 19, 2024

Latest News